News & Updates

Show Multimedia Only

Vitamin D levels inversely linked to depression in young people

18 Sep 2023

Early adolescents with higher vitamin D levels at baseline appear to be at lower risk of depression, a study has found.

Vitamin D levels inversely linked to depression in young people

18 Sep 2023

Multipronged approach pushed to optimize statin therapy in Singapore

16 Sep 2023 by

There are several important barriers to statin therapy optimization among patients with hyperlipidaemia who are at very high risk of cardiovascular disease (CVD), as reported by a group of local researchers.

Multipronged approach pushed to optimize statin therapy in Singapore

16 Sep 2023

Lower testosterone, increased LH levels indicate impaired testicular function in older men

15 Sep 2023

Several factors contribute to the variation in male testosterone, sex hormone-binding globulin (SHBG), and luteinizing hormone (LH) concentrations, suggests a study. Moreover, reduced testosterone and elevated LH levels appear to be signs of an impaired testicular function after age 70 years.

Lower testosterone, increased LH levels indicate impaired testicular function in older men

15 Sep 2023

COVID-19 booster may cause transient glycaemic elevations in T1D

15 Sep 2023

Individuals with type 1 diabetes (T1D) may experience mild, temporary glycaemic elevations following receipt of a COVID-19 booster vaccine, according to a study.

COVID-19 booster may cause transient glycaemic elevations in T1D

15 Sep 2023

Triple G agonist shows therapeutic potential in obesity

11 Sep 2023

Treatment with retatrutide, the novel agonist of the glucose-dependent insulinotropic polypeptide, glucagon-like peptide 1, and glucagon receptors, leads to marked reductions in body weight in individuals with obesity, as shown in the results of a phase II trial.

Triple G agonist shows therapeutic potential in obesity

11 Sep 2023

Avocado-containing diet may improve glucose control in T2D

11 Sep 2023 by

Following a diet that contains avocado appears to be beneficial to individuals with type 2 diabetes (T2D), being associated with lower average glucose levels.

Avocado-containing diet may improve glucose control in T2D

11 Sep 2023

Weight loss with high-dose oral semaglutide in obese nondiabetics

06 Sep 2023 by

A higher dose of oral semaglutide than the currently approved 14 mg/day dose may be the next option for overweight or obese patients wanting to lose pounds.

Weight loss with high-dose oral semaglutide in obese nondiabetics

06 Sep 2023

Female sex protective against obesity-driven dysregulation of glucose metabolism

04 Sep 2023 by

Insulin sensitivity and secretion differ by sex among Asians without diabetes, reveals a study, noting that female sex is protective on obesity-driven dysregulation of glucose metabolism.

Female sex protective against obesity-driven dysregulation of glucose metabolism

04 Sep 2023

Metformin shows potential as a low-cost antiageing medication

04 Sep 2023 by

Metformin may promote healthy ageing via targeting GPD1 and AMPKγ2, a Mendelian randomization study by the University of Hong Kong (HKU) has shown.

Metformin shows potential as a low-cost antiageing medication

04 Sep 2023

A new era is dawning in diabetes treatment, and incretin therapy with GLP1 receptor agonists (GLP1-RAs) like Dulaglutide is emerging as a pivotal solution for breaking through the constraints of clinical inertia.

04 Sep 2023 by

In the realm of modern medicine, the term "clinical inertia" has gained significant attention for its potential to hinder effective disease management. Within the context of diabetes management, clinical inertia refers to the delay or reluctance in intensifying therapy despite clear indications for doing so, such as not achieving their target HbA1c goal.¹ Fortunately, a new era is dawning in diabetes treatment, and incretin therapy with GLP1 receptor agonists (GLP1-RAs) like Dulaglutide is emerging as a pivotal solution for breaking through the constraints of clinical inertia.

A new era is dawning in diabetes treatment, and incretin therapy with GLP1 receptor agonists (GLP1-RAs) like Dulaglutide is emerging as a pivotal solution for breaking through the constraints of clinical inertia.

04 Sep 2023

News & Updates

Showing Endocrinology articles

Showing

Specialty:

Vitamin D levels inversely linked to depression in young people

Vitamin D levels inversely linked to depression in young people

Multipronged approach pushed to optimize statin therapy in Singapore

Multipronged approach pushed to optimize statin therapy in Singapore

Lower testosterone, increased LH levels indicate impaired testicular function in older men

Lower testosterone, increased LH levels indicate impaired testicular function in older men

COVID-19 booster may cause transient glycaemic elevations in T1D

COVID-19 booster may cause transient glycaemic elevations in T1D

Triple G agonist shows therapeutic potential in obesity

Triple G agonist shows therapeutic potential in obesity

Avocado-containing diet may improve glucose control in T2D

Avocado-containing diet may improve glucose control in T2D

Weight loss with high-dose oral semaglutide in obese nondiabetics

Weight loss with high-dose oral semaglutide in obese nondiabetics

Female sex protective against obesity-driven dysregulation of glucose metabolism

Female sex protective against obesity-driven dysregulation of glucose metabolism

Metformin shows potential as a low-cost antiageing medication

Metformin shows potential as a low-cost antiageing medication

A new era is dawning in diabetes treatment, and incretin therapy with GLP1 receptor agonists (GLP1-RAs) like Dulaglutide is emerging as a pivotal solution for breaking through the constraints of clinical inertia.

A new era is dawning in diabetes treatment, and incretin therapy with GLP1 receptor agonists (GLP1-RAs) like Dulaglutide is emerging as a pivotal solution for breaking through the constraints of clinical inertia.